Liu, Nan
Lin, Xiaoli
Huang, Chengying
Article History
Received: 11 June 2019
Revised: 2 November 2019
Accepted: 8 November 2019
First Online: 10 December 2019
Competing interests
: The authors declare no competing interests.
: Ethics approval was not required for this study. The SKOV3 cell line was purchased from ATCC (ATCC-HTB-77). OVCA429 cells were obtained from the Laboratory of Gynecologic Oncology at Brigham and Women’s Hospital (Boston, Massachusetts, USA).
: This work was supported by Science and Technology Planning Project of Guangdong Province of China (2014A020212188).
: Not applicable.
: All presented data are available from the corresponding author upon reasonable request.